社交媒体用于药物警戒:Vigi4Med项目主要发现与建议
法国Vigi4Med项目评估了社交媒体(主要是网络论坛)用于药物警戒活动的价值,基于文献分析提出伦理、质量和定量三类建议。项目认为信息技术进步和患者体验的社会需求应推动社交媒体监测研究,以强化传统药物警戒。
要点
- 社交媒体药物警戒需解决数据提取、标注和过滤等技术挑战
- 建议涵盖伦理(隐私、保密、随访)、质量(信息质量)和定量(统计分析)三方面
- 社交媒体除信号检测外,还可支持其他药物警戒活动
核心结论
- 社交媒体监测有望强化传统药物警戒,但需在伦理、质量和定量方面建立规范
研究设计与样本
- 法国Vigi4Med研究项目,评估社交媒体(主要为网络论坛)用于药物警戒活动,并纳入现有文献分析
主要发现
- 文献主要关注信号检测,社交媒体支持其他药物警戒活动的潜在价值尚待探索
- 社交媒体药物警戒仍缺乏系统探索和应用的明确共识
关键数值与推荐
- 建议分为三类:伦理(隐私、保密、随访)、质量(信息质量)、定量(统计分析)
临床怎么用
- 临床药学智能体可参考三类建议框架,在利用社交媒体信息时关注隐私保护、信息质量评估和统计分析方法
局限性
- 原文未报告具体研究样本量、数据来源细节及建议的循证等级
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The large-scale use of social media by the population has gained the attention of stakeholders and researchers in various fields. In the domain of pharmacovigilance, this new resource was initially considered as an opportunity to overcome underreporting and monitor the safety of drugs in real time in close connection with patients. Research is still required to overcome technical challenges related to data extraction, annotation, and filtering, and there is not yet a clear consensus concerning the systematic exploration and use of social media in pharmacovigilance. Although the literature has mainly considered signal detection, the potential value of social media to support other pharmacovigilance activities should also be explored. The objective of this paper is to present the main findings and subsequent recommendations from the French research project Vigi4Med, which evaluated the use of social media, mainly web forums, for pharmacovigilance activities. This project included an analysis of the existing literature, which contributed to the recommendations presented herein. The recommendations are categorized into three categories: ethical (related to privacy, confidentiality, and follow-up), qualitative (related to the quality of the information), and quantitative (related to statistical analysis). We argue that the progress in information technology and the societal need to consider patients' experiences should motivate future research on social media surveillance for the reinforcement of classical pharmacovigilance.
引用
- Audeh B, Bellet F, Beyens MN, et al. Use of Social Media for Pharmacovigilance Activities: Key Findings and Recommendations from the Vigi4Med Project. Drug Saf. 2020. PMID: 32557179. doi:10.1007/s40264-020-00951-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。